Description: According to Transpire Insight's Alzheimer therapeutics research, the market is increasingly moving toward disease-modifying treatments supported by biomarker-based diagnosis and earlier intervention. Transpire Insight's North America Alzheimer Therapeutics Market was valued at USD 2.08 billion in 2025 and is projected to reach USD 8.32 billion by 2033, expanding at a CAGR of 18.95% during 2026–2033
Category: Health & Fitness
Tag: Alzheimer's Drugs